Safety and Efficacy of Ranolazine for the Treatment of Amyotrophic Lateral Sclerosis
Phase of Trial: Phase II
Latest Information Update: 27 Jun 2018
At a glance
- Drugs Ranolazine (Primary)
- Indications Amyotrophic lateral sclerosis
- Focus Adverse reactions
- 17 Jun 2018 Planned End Date changed from 1 Jun 2019 to 11 Jun 2019.
- 17 Jun 2018 Planned primary completion date changed from 1 Jun 2019 to 11 Jun 2019.
- 17 Jun 2018 Status changed from not yet recruiting to recruiting.